Minovia Therapeutics
Natalie Yivgi-Ohana is currently working at 8400 The Health Network as a Member since September 2019. Alongside this role, Natalie also holds the position of CEO at Minovia Therapeutics since December 2011. Natalie previously worked as a Postdoctoral fellow at the Weizmann Institute of Science from 2007 to 2010. Natalie obtained their Ph.D. in Biochemistry from The Hebrew University of Jerusalem in 2007, a Master's Degree in Human Reproduction from Bar-Ilan University in 2002, and a B.Sc. in Medical Sciences from Ben-Gurion University of the Negev in 1999.
This person is not in any offices
Minovia Therapeutics
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.